Physicians at the University of Illinois Hospital & Health Sciences System have cured 12 adult patients of sickle cell disease using a unique procedure for stem cell transplantation from healthy, tissue-matched siblings.
The transplants were the first to be performed outside of the National Institutes of Health campus in Maryland, where the procedure was developed. Physicians there have treated 30 patients, with an 87 percent success rate. The results of the phase I/II clinical trial at UI Health, in which 92 percent of treated patients were cured, are published online in the journal Biology of Blood & Marrow Transplantation.
The new technique eliminates the need for chemotherapy to prepare the patient to receive the transplanted cells and offers the prospect of cure for tens of thousands of adults suffering from sickle cell disease.
About 90 percent of the approximately 450 patients who have received stem cell transplants for sickle cell disease have been children. Chemotherapy has been considered too risky for adult patients, who are often more weakened than children by the disease.
“Adults with sickle cell disease are now living on average until about age 50 with blood transfusions and drugs to help with pain crises, but their quality of life can be very low,” says Dr. Damiano Rondelli, chief of hematology/oncology and director of the blood and marrow transplant program at UI Health, and corresponding author on the paper.
“Now, with this chemotherapy-free transplant, we are curing adults with sickle cell disease, and we see that their quality of life improves vastly within just one month of the transplant,” said Rondelli, who is also the Michael Reese Professor of Hematology in the UIC College of Medicine. “They are able to go back to school, go back to work, and can experience life without pain.”
Sickle cell disease is inherited. It primarily affects people of African descent, including about one in every 500 African Americans born in the U.S. The defect causes the oxygen-carrying red blood cells to be crescent shaped, like a sickle. The misshapen cells deliver less oxygen to the body’s tissues, causing severe pain and eventually stroke or organ damage.
Doctors have known for some time that bone marrow transplantation from a healthy donor can cure sickle cell disease. But few adults were transplanted because high-dose chemotherapy was needed to kill off the patients’ own blood-forming cells — and their entire immune system, to prevent rejection of the transplanted cells, leaving patients open to infection.
In the new procedure, patients receive immunosuppressive drugs just before the transplant, along with a very low dose of total body irradiation — a treatment much less harsh and with fewer potentially serious side effects than chemotherapy.
Next, donor cells from a healthy and tissue-matched sibling are transfused into the patient. Stem cells from the donor produce healthy new blood cells in the patient, eventually in sufficient quantity to eliminate symptoms. In many cases, sickle cells can no longer be detected. Patients must continue to take immunosuppressant drugs for at least a year.
In the reported trial, the researchers transplanted 13 patients, 17 to 40 years of age, with a stem cell preparation from the blood of a tissue-matched sibling. Healthy sibling donor-candidates and patients were tested for human leukocyte antigen, a set of markers found on cells in the body. Ten of these HLA markers must match between the donor and the recipient for the transplant to have the best chance of evading rejection.
In a further advance of the NIH procedure, physicians at UI Health successfully transplanted two patients with cells from siblings who matched for HLA but had a different blood type.
In all 13 patients, the transplanted cells successfully took up residence in the marrow and produced healthy red blood cells. One patient who failed to follow the post-transplant therapy regimen reverted to the original sickle cell condition.
None of the patients experienced graft-versus-host disease, a condition where immune cells originating from the donor attack the recipient’s body.
One year after transplantation, the 12 successfully transplanted patients had normal hemoglobin concentrations in their blood and better cardiopulmonary function. They reported less pain and improved health and vitality.
Four of the patients were able to stop post-transplantation immunotherapy without transplant rejection or other complications.
The Latest on: Sickle cell disease
[google_news title=”” keyword=”Sickle cell disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Sickle cell disease
- ‘Blessing for both of us to be cured’: Siblings with sickle cell see finish lineon March 1, 2024 at 4:58 pm
Two siblings with sickle cell disease have found two different cures to a disease that they’ve been battling since birth.
- Sickle cell and COVID-19: A risky mix of two diseaseson February 29, 2024 at 10:19 am
UdeM's Stéphanie Forté and co-researchers in Canada and Brazil have shown how people with sickle cell disease or sickle cell trait have a higher chance of dying from COVID-19 than the general ...
- Higher COVID-19 death risk found in sickle cell disease and trait patientson February 28, 2024 at 3:59 pm
With Michelon as the first author, a large-scale effort was undertaken to collect and analyze 22 studies in a meta-analysis, including nearly 1,900 people with sickle cell disease, 8,700 people ...
- Massachusetts-based companies behind groundbreaking treatment for sickle cell diseaseon February 28, 2024 at 12:25 pm
Both companies that developed these gene therapy options are based here in Massachusetts. There are some risks involved, including infertility. There is also the cost. This is a multi-million-dollar ...
- RG&E, Red Cross host blood drive to raise awareness on sickle cell diseaseon February 27, 2024 at 12:50 pm
The American Red Cross of WNY teamed up with RG&E for a blood drive to help raise awareness about sickle cell disease, which can lead to a host of other serious health problems. The condition impacts ...
- Conquering sickle cell disease | The introduction of gene therapies and the call for blood donationson February 27, 2024 at 3:16 am
NORFOLK, Va. — Medical advancements are making life easier for some people who live with sickle cell disease. It affects roughly 100,000 people in the U.S., according to the Centers for Disease ...
- Miracle Moment: Living with sickle cell diseaseon February 25, 2024 at 3:59 pm
Sickle cell disease is a genetic and hereditary affliction where hemoglobin clumps together on one side of the red blood cell after releasing oxygen, causing the cell to sickle. The pain associated ...
- Darling Dash: The race to end sickle cell deaths; how disease is taking a toll on Black communityon February 23, 2024 at 2:40 pm
HOUSTON, Texas (KTRK) -- Sickle cell anemia is a disease that occurs among about one out of every 365 Black or African-American births. That's according to the Centers for Disease Control, which has ...
- New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggleon February 23, 2024 at 8:01 am
Health officials are trying to find ways to ensure equitable access to the breakthrough, high-cost gene therapies for sickle cell disease. The disease, which can cause bouts of debilitating pain ...
- Arizona is in critical need of blood donations for sickle cell disease patientson February 22, 2024 at 6:58 pm
A lapse in blood donations has caused a critical blood shortage in Arizona and is affecting sickle cell disease patients. Maintaining a diverse blood supply is especially important for African ...
via Bing News